Log in to search using one of your social media accounts:

 

Two Drugs Offer Hope Against Prostate Cancer

Two cancer drugs can stall the progression of a particularly hard-to-treat form of prostate cancer, a pair of new trials shows.
Source: WebMD Health - Category: Consumer Health News Source Type: news

Related Links:

Enzalutamide may have a role in prostate cancer therapy, but randomized trials are needed, says Dr Chodak.Medscape Urology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Urology Commentary Source Type: news
Condition:   Prostate Cancer Recurrent Intervention:   Drug: Ga-68 P16-093 PET/CT scan Sponsors:   Five Eleven Pharma, Inc.;   Indiana University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Cancer of Prostate;   Insomnia Intervention:   Behavioral: 12-week aerobic exercise and cognitive-behavioral therapy Sponsor:   Danish Cancer Society Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Prostate Cancer Recurrent Intervention:   Diagnostic Test: 68Ga-HBED-CC-PSMA PET / CT Sponsor:   Institut Cancerologie de l'Ouest Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
The presenter had surgery for prostate cancer and says "it all seemed to go pretty well".
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
PROSTATE cancer symptoms don ’t usually show until the latter stages of the disease. After Stephen Fry was diagnosed with the condition, what are the signs to look out for?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
STEPHEN FRY revealed today he has been battling prostate cancer, but what are symptoms of the condition, how can you test for it, and what treatment can you expect?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
ConclusionsEarlier induction of docetaxel in nmCRPC patients may prolong OS. Further prospective studies in more patients will be required to confirm our findings.
Source: The Prostate - Category: Urology & Nephrology Authors: Tags: ORIGINAL ARTICLE Source Type: research
CONCLUSIONS: The combination of TBx and SBx achieved the best results for the detection and prognosis of PCa-s. The use of SBx alone would have missed the detection of PCa-s in 12% of patients. PMID: 29463177 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Urology - Category: Urology & Nephrology Tags: Scand J Urol Source Type: research
CONCLUSIONS: Low-dose brachytherapy offers good short- to intermediate-term cancer control in selected men with localized PCa. Further studies are needed for safety analyses and for comparison with other treatment modalities. PMID: 29463165 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Urology - Category: Urology & Nephrology Tags: Scand J Urol Source Type: research
More News: Cancer | Cancer & Oncology | Health | Prostate Cancer